These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33348546)

  • 21. Long-lived intestinal tuft cells serve as colon cancer-initiating cells.
    Westphalen CB; Asfaha S; Hayakawa Y; Takemoto Y; Lukin DJ; Nuber AH; Brandtner A; Setlik W; Remotti H; Muley A; Chen X; May R; Houchen CW; Fox JG; Gershon MD; Quante M; Wang TC
    J Clin Invest; 2014 Mar; 124(3):1283-95. PubMed ID: 24487592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases.
    Ali N; Chandrakesan P; Nguyen CB; Husain S; Gillaspy AF; Huycke M; Berry WL; May R; Qu D; Weygant N; Sureban SM; Bronze MS; Dhanasekaran DN; Houchen CW
    Oncotarget; 2015 Aug; 6(24):20327-44. PubMed ID: 25948779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer.
    Vijai M; Baba M; Ramalingam S; Thiyagaraj A
    Oncol Lett; 2021 Dec; 22(6):850. PubMed ID: 34733368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory network analysis of
    Valenti G; Laise P; Takahashi R; Wu F; Ruan T; Vasciaveo A; Jiang Z; Sunagawa M; Middelhoff M; Nienhüser H; Fu N; Malagola E; Hayakawa Y; Iuga AC; Califano A; Wang TC
    bioRxiv; 2024 Oct; ():. PubMed ID: 39257805
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel double-targeted nondrug delivery system for targeting cancer stem cells.
    Qiao S; Zhao Y; Geng S; Li Y; Hou X; Liu Y; Lin FH; Yao L; Tian W
    Int J Nanomedicine; 2016; 11():6667-6678. PubMed ID: 27994463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner.
    Razi S; Sadeghi A; Asadi-Lari Z; Tam KJ; Kalantari E; Madjd Z
    Clin Exp Med; 2021 Feb; 21(1):139-147. PubMed ID: 32965580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma.
    Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
    World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DCLK1 is Overexpressed and Associated with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Velázquez-Enríquez JM; Cerna R; Beltrán-Ramírez O; Piña-Vázquez C; Villa-Treviño S; Vásquez-Garzón VR
    Biochem Genet; 2024 Dec; 62(6):4280-4302. PubMed ID: 38294590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch signaling drives development of Barrett's metaplasia from Dclk1-positive epithelial tuft cells in the murine gastric mucosa.
    Kunze B; Middelhoff M; Maurer HC; Agibalova T; Anand A; Bührer AM; Fang HY; Baumeister T; Steiger K; Strangmann J; Schmid RM; Wang TC; Quante M
    Sci Rep; 2021 Feb; 11(1):4509. PubMed ID: 33627749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase.
    Weygant N; Ge Y; Qu D; Kaddis JS; Berry WL; May R; Chandrakesan P; Bannerman-Menson E; Vega KJ; Tomasek JJ; Bronze MS; An G; Houchen CW
    Cancer Res; 2016 Jul; 76(14):4090-9. PubMed ID: 27287716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
    Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
    Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma.
    Nevi L; Di Matteo S; Carpino G; Zizzari IG; Samira S; Ambrosino V; Costantini D; Overi D; Giancotti A; Monti M; Bosco D; De Peppo V; Oddi A; De Rose AM; Melandro F; Bragazzi MC; Faccioli J; Massironi S; Grazi GL; Panici PB; Berloco PB; Giuliante F; Cardinale V; Invernizzi P; Caretti G; Gaudio E; Alvaro D
    Hepatology; 2021 Jan; 73(1):144-159. PubMed ID: 32978808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1.
    Ikezono Y; Koga H; Akiba J; Abe M; Yoshida T; Wada F; Nakamura T; Iwamoto H; Masuda A; Sakaue T; Yano H; Tsuruta O; Torimura T
    Mol Cancer Res; 2017 Jun; 15(6):744-752. PubMed ID: 28179411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis.
    Kalantari E; Razmi M; Tajik F; Asadi-Lari M; Ghods R; Madjd Z
    Cancer Cell Int; 2022 Jun; 22(1):217. PubMed ID: 35717205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DCLK1 Plays a Metastatic-Promoting Role in Human Breast Cancer Cells.
    Liu H; Wen T; Zhou Y; Fan X; Du T; Gao T; Li L; Liu J; Yang L; Yao J; Ge Y; An G
    Biomed Res Int; 2019; 2019():1061979. PubMed ID: 31223610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dclk1-expressing tuft cells: critical modulators of the intestinal niche?
    Middelhoff M; Westphalen CB; Hayakawa Y; Yan KS; Gershon MD; Wang TC; Quante M
    Am J Physiol Gastrointest Liver Physiol; 2017 Oct; 313(4):G285-G299. PubMed ID: 28684459
    [No Abstract]   [Full Text] [Related]  

  • 37. Dclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewal.
    Chandrakesan P; May R; Qu D; Weygant N; Taylor VE; Li JD; Ali N; Sureban SM; Qante M; Wang TC; Bronze MS; Houchen CW
    Oncotarget; 2015 Oct; 6(31):30876-86. PubMed ID: 26362399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas.
    Shafiei S; Kalantari E; Saeednejad Zanjani L; Abolhasani M; Asadi Lari MH; Madjd Z
    Exp Mol Pathol; 2019 Jun; 108():164-172. PubMed ID: 31028726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer.
    Tao H; Tanaka T; Okabe K
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1449-1459. PubMed ID: 28382517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.